Selective Loss of Brain-Derived Neurotrophic Factor in the Dentate Gyrus Attenuates Antidepressant Efficacy

Megumi Adachi, Michel Barrot, Anita E. Autry, David Theobald, Lisa M Monteggia

Research output: Contribution to journalArticle

235 Citations (Scopus)

Abstract

Background: Brain-derived neurotrophic factor (BDNF) plays an important role in neural plasticity in the adult nervous system and has been suggested as a target gene for antidepressant treatment. The neurotrophic hypothesis of depression suggests that loss of BDNF from the hippocampus contributes to an increased vulnerability for depression, whereas upregulation of BDNF in the hippocampus is suggested to mediate antidepressant efficacy. Methods: We have used a viral-mediated gene transfer approach to assess the role of BDNF in subregions of the hippocampus in a broad array of behavioral paradigms, including depression-like behavior and antidepressant responses. We have combined the adeno-associated virus (AAV) with the Cre/loxP site-specific recombination system to induce the knockout of BDNF selectively in either the CA1 or dentate gyrus (DG) subregions of the hippocampus. Results: We show that the loss of BDNF in either the CA1 or the DG of the hippocampus does not alter locomotor activity, anxiety-like behavior, fear conditioning, or depression-related behaviors. However, the selective loss of BDNF in the DG but not the CA1 region attenuates the actions of desipramine and citalopram in the forced swim test. Conclusions: These data suggest that the loss of hippocampal BDNF per se is not sufficient to mediate depression-like behavior. However, these results support the view that BDNF in the DG might be essential in mediating the therapeutic effect of antidepressants.

Original languageEnglish (US)
Pages (from-to)642-649
Number of pages8
JournalBiological Psychiatry
Volume63
Issue number7
DOIs
StatePublished - Apr 1 2008

Fingerprint

Brain-Derived Neurotrophic Factor
Dentate Gyrus
Antidepressive Agents
Depression
Hippocampus
Parahippocampal Gyrus
Dependovirus
Citalopram
Neuronal Plasticity
Desipramine
Viral Genes
Therapeutic Uses
Locomotion
Nervous System
Genetic Recombination
Fear
Up-Regulation
Anxiety

Keywords

  • Animal model
  • antidepressant
  • BDNF
  • behavior
  • hippocampus
  • viral mediated gene transfer

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Selective Loss of Brain-Derived Neurotrophic Factor in the Dentate Gyrus Attenuates Antidepressant Efficacy. / Adachi, Megumi; Barrot, Michel; Autry, Anita E.; Theobald, David; Monteggia, Lisa M.

In: Biological Psychiatry, Vol. 63, No. 7, 01.04.2008, p. 642-649.

Research output: Contribution to journalArticle

Adachi, Megumi ; Barrot, Michel ; Autry, Anita E. ; Theobald, David ; Monteggia, Lisa M. / Selective Loss of Brain-Derived Neurotrophic Factor in the Dentate Gyrus Attenuates Antidepressant Efficacy. In: Biological Psychiatry. 2008 ; Vol. 63, No. 7. pp. 642-649.
@article{dd208fb4127844f88758e60bdc0acb64,
title = "Selective Loss of Brain-Derived Neurotrophic Factor in the Dentate Gyrus Attenuates Antidepressant Efficacy",
abstract = "Background: Brain-derived neurotrophic factor (BDNF) plays an important role in neural plasticity in the adult nervous system and has been suggested as a target gene for antidepressant treatment. The neurotrophic hypothesis of depression suggests that loss of BDNF from the hippocampus contributes to an increased vulnerability for depression, whereas upregulation of BDNF in the hippocampus is suggested to mediate antidepressant efficacy. Methods: We have used a viral-mediated gene transfer approach to assess the role of BDNF in subregions of the hippocampus in a broad array of behavioral paradigms, including depression-like behavior and antidepressant responses. We have combined the adeno-associated virus (AAV) with the Cre/loxP site-specific recombination system to induce the knockout of BDNF selectively in either the CA1 or dentate gyrus (DG) subregions of the hippocampus. Results: We show that the loss of BDNF in either the CA1 or the DG of the hippocampus does not alter locomotor activity, anxiety-like behavior, fear conditioning, or depression-related behaviors. However, the selective loss of BDNF in the DG but not the CA1 region attenuates the actions of desipramine and citalopram in the forced swim test. Conclusions: These data suggest that the loss of hippocampal BDNF per se is not sufficient to mediate depression-like behavior. However, these results support the view that BDNF in the DG might be essential in mediating the therapeutic effect of antidepressants.",
keywords = "Animal model, antidepressant, BDNF, behavior, hippocampus, viral mediated gene transfer",
author = "Megumi Adachi and Michel Barrot and Autry, {Anita E.} and David Theobald and Monteggia, {Lisa M}",
year = "2008",
month = "4",
day = "1",
doi = "10.1016/j.biopsych.2007.09.019",
language = "English (US)",
volume = "63",
pages = "642--649",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "7",

}

TY - JOUR

T1 - Selective Loss of Brain-Derived Neurotrophic Factor in the Dentate Gyrus Attenuates Antidepressant Efficacy

AU - Adachi, Megumi

AU - Barrot, Michel

AU - Autry, Anita E.

AU - Theobald, David

AU - Monteggia, Lisa M

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Background: Brain-derived neurotrophic factor (BDNF) plays an important role in neural plasticity in the adult nervous system and has been suggested as a target gene for antidepressant treatment. The neurotrophic hypothesis of depression suggests that loss of BDNF from the hippocampus contributes to an increased vulnerability for depression, whereas upregulation of BDNF in the hippocampus is suggested to mediate antidepressant efficacy. Methods: We have used a viral-mediated gene transfer approach to assess the role of BDNF in subregions of the hippocampus in a broad array of behavioral paradigms, including depression-like behavior and antidepressant responses. We have combined the adeno-associated virus (AAV) with the Cre/loxP site-specific recombination system to induce the knockout of BDNF selectively in either the CA1 or dentate gyrus (DG) subregions of the hippocampus. Results: We show that the loss of BDNF in either the CA1 or the DG of the hippocampus does not alter locomotor activity, anxiety-like behavior, fear conditioning, or depression-related behaviors. However, the selective loss of BDNF in the DG but not the CA1 region attenuates the actions of desipramine and citalopram in the forced swim test. Conclusions: These data suggest that the loss of hippocampal BDNF per se is not sufficient to mediate depression-like behavior. However, these results support the view that BDNF in the DG might be essential in mediating the therapeutic effect of antidepressants.

AB - Background: Brain-derived neurotrophic factor (BDNF) plays an important role in neural plasticity in the adult nervous system and has been suggested as a target gene for antidepressant treatment. The neurotrophic hypothesis of depression suggests that loss of BDNF from the hippocampus contributes to an increased vulnerability for depression, whereas upregulation of BDNF in the hippocampus is suggested to mediate antidepressant efficacy. Methods: We have used a viral-mediated gene transfer approach to assess the role of BDNF in subregions of the hippocampus in a broad array of behavioral paradigms, including depression-like behavior and antidepressant responses. We have combined the adeno-associated virus (AAV) with the Cre/loxP site-specific recombination system to induce the knockout of BDNF selectively in either the CA1 or dentate gyrus (DG) subregions of the hippocampus. Results: We show that the loss of BDNF in either the CA1 or the DG of the hippocampus does not alter locomotor activity, anxiety-like behavior, fear conditioning, or depression-related behaviors. However, the selective loss of BDNF in the DG but not the CA1 region attenuates the actions of desipramine and citalopram in the forced swim test. Conclusions: These data suggest that the loss of hippocampal BDNF per se is not sufficient to mediate depression-like behavior. However, these results support the view that BDNF in the DG might be essential in mediating the therapeutic effect of antidepressants.

KW - Animal model

KW - antidepressant

KW - BDNF

KW - behavior

KW - hippocampus

KW - viral mediated gene transfer

UR - http://www.scopus.com/inward/record.url?scp=40149097433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40149097433&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2007.09.019

DO - 10.1016/j.biopsych.2007.09.019

M3 - Article

VL - 63

SP - 642

EP - 649

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 7

ER -